Trial overview.
obesity
OBESITY
Participants with obesity participated in a pre-intervention session before being randomly assigned to the treatment (liraglutide) or placebo (control) group. During this first test session, they performed a liking task in the scanner. Biomedical measures were also taken, and they performed other experimental tasks not described here. After 16 weeks of treatment, they came back to the laboratory and went through a second test session.